Observation of the therapeutic effects of gatifloxacin on community acquired pneumonia

Chinese Journal of Antibiotics

Volumn 32, Issue 5, 2007, Pages 313-315

  Li, Hong Yun ^a   Qin, Chao ^a   Liu, Qian ^a   Fu, Qun ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Clearance of pathogens; Clinical therapeutic effects; Community acquired pneumonia; Gatifloxacin

Indexed keywords

CEFUROXIME; GATIFLOXACIN;

ANALYTIC METHOD; ANTIBIOTIC THERAPY; ARTICLE; CARBOHYDRATE ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; DRUG EFFICACY; GASTROINTESTINAL SYMPTOM; HOSPITALIZATION; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; LIVER DYSFUNCTION; LIVER FUNCTION; MAJOR CLINICAL STUDY; NAUSEA; NONHUMAN; RIDIT TEST; SIDE EFFECT; STATISTICAL SIGNIFICANCE; VOMITING;

EID: 34447499938     PISSN: 10018689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Chinese source
2. Perry C M, Ormrod D, Hurst M, et al. Gatifloxacin: a review of its use in the management of bacterial infections [J]. Drugs, 2002, 62(3):169
3. Chinese source
4. Chinese source
5. Chinese source
6. Chinese source
7. Chinese source
8. Chinese source
9. Chinese source
10. Jones R N, Pfalter M, Andes D R, et al. Gatifloxacin used for therapy of outpatient community-acquired pneumonia caused by Streptococcus pneumoniae [J]. Diagn Microbiol Infect Dis, 2002, 44(1):93